{"id":"W2753741461","doi":"10.1158/0008-5472.can-17-0707","title":"CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; Institut du Savoir Montfort; Centre Hospitalier de l’Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Medical Research Council; Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Fonds De La Recherche Scientifique - FNRS; National Health and Medical Research Council; Breast Cancer Research Foundation; Susan G. Komen for the Cure","keywords":"Trastuzumab; Cancer research; Immune system; Stromal cell; Antibody; Cancer cell; Medicine; Monoclonal antibody; Breast cancer; Cancer; Immunology; Biology; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001151333,0.0001537377,0.0002733547,0.0001714265,0.0007958186,0.0002205353,0.0005792705,0.00009908334,0.0009402561],"category_scores_gemma":[0.0002125057,0.0001207924,0.0001041155,0.0002826453,0.0004123276,0.0001359359,0.0001157496,0.0003944397,0.0001249427],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002933856,"about_ca_system_score_gemma":0.000540346,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001644715,"about_ca_topic_score_gemma":0.000720021,"domain_scores_codex":[0.9978066,0.00008973726,0.0002031627,0.000469618,0.0007865025,0.0006443475],"domain_scores_gemma":[0.9978948,0.00006554206,0.00006461258,0.001309962,0.0004181035,0.0002469994],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.008059503,0.0001638052,0.02364346,0.000146318,0.0001845793,0.0000931734,0.0007247302,2.145734e-7,0.8427351,0.0001504337,0.0454374,0.07866127],"study_design_scores_gemma":[0.002601046,0.0005170637,0.2009431,0.0006113898,0.000006854134,0.000006206449,0.0001021236,0.000002442623,0.21457,0.0001878442,0.5802581,0.0001938727],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9450909,0.007263843,0.00001817725,0.03025838,0.0003331375,0.001245865,0.00002545047,0.00005565539,0.01570854],"genre_scores_gemma":[0.9596246,0.004934776,0.0002041471,0.0007930844,0.0006461357,0.0002929375,0.000007619679,0.00004821952,0.0334484],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6281651,"threshold_uncertainty_score":0.999973,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1319793339646701,"score_gpt":0.4944404438853889,"score_spread":0.3624611099207188,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}